New Model for End Stage Liver Disease Improves Prognostic Capability After Transjugular Intrahepatic Portosystemic Shunt

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 11, 2009, Pages 1236-1240

  Guy, Jennifer ^a,b   Somsouk, Ma ^a,b   Shiboski, Stephen ^a   Kerlan, Robert ^b   Inadomi, John M ^a,b   Biggins, Scott W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASCITES; DEATH; DISEASE COURSE; ESOPHAGUS VARICES BLEEDING; FEMALE; HEALTH CENTER; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT CODING; PREDICTOR VARIABLE; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SODIUM BLOOD LEVEL; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ADULT; FEMALE; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED; MODELS, STATISTICAL; PORTASYSTEMIC SHUNT, SURGICAL; PROGNOSIS; RETROSPECTIVE STUDIES; SERUM; SEVERITY OF ILLNESS INDEX; SODIUM; TREATMENT OUTCOME;

EID: 71749121376     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.06.009     Document Type: Article

References (33)

1. Gines P., Cardenas A., Arroyo V., et al. Management of cirrhosis and ascites. N Engl J Med 350 (2004) 1646-1654
2. Chalasani N., Kahi C., Francois F., et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 98 (2003) 653-659
3. D'Amico G., and De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38 (2003) 599-612
4. Thomopoulos K., Theocharis G., Mimidis K., et al. Improved survival of patients presenting with acute variceal bleeding. Prognostic indicators of short- and long-term mortality. Dig Liver Dis 38 (2006) 899-904
5. Boyer T.D., and Haskal Z.J. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 41 (2005) 386-400
6. Jalan R., Elton R.A., Redhead D.N., et al. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 23 (1995) 123-128
7. Chalasani N., Clark W.S., Martin L.G., et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 118 (2000) 138-144
8. Malinchoc M., Kamath P.S., Gordon F.D., et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31 (2000) 864-871
9. Brensing K.A., Raab P., Textor J., et al. Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis. Eur J Gastroenterol Hepatol 14 (2002) 723-731
10. Schepke M., Roth F., Fimmers R., et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 98 (2003) 1167-1174
11. Angermayr B., Cejna M., Karnel F., et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 52 (2003) 879-885
12. Ferral H., Gamboa P., Postoak D.W., et al. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology 231 (2004) 231-236
13. Luca A., Angermayr B., Bertolini G., et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 13 (2007) 1174-1180
14. Arroyo V., Rodes J., Gutierrez-Lizarraga M.A., et al. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis 21 (1976) 249-256
15. Fernandez-Esparrach G., Sanchez-Fueyo A., Gines P., et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 34 (2001) 46-52
16. Heuman D.M., Abou-Assi S.G., Habib A., et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 40 (2004) 802-810
17. Ruf A.E., Kremers W.K., Chavez L.L., et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 11 (2005) 336-343
18. Biggins S.W., Rodriguez H.J., Bacchetti P., et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 41 (2005) 32-39
19. Biggins S.W., Kim W.R., Terrault N.A., et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 130 (2006) 1652-1660
20. Kim W.R., Biggins S.W., Kremers W.K., et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 359 (2008) 1018-1026
21. Mathur S., Gane E.J., McCall J.L., et al. Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosis. J Gastroenterol Hepatol 23 (2008) 239-243
22. Kamath P.S., Wiesner R.H., Malinchoc M., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 (2001) 464-470
23. Harrell Jr. F.E., Califf R.M., Pryor D.B., et al. Evaluating the yield of medical tests. JAMA 247 (1982) 2543-2546
24. Salerno F., Camma C., Enea M., et al. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 133 (2007) 825-834
25. Wiesner R., Edwards E., Freeman R., et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124 (2003) 91-96
26. Patch D., Nikolopoulou V., McCormick A., et al. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol 28 (1998) 454-460
27. Escorsell A., Banares R., Garcia-Pagan J.C., et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 35 (2002) 385-392
28. Ochs A., Rossle M., Haag K., et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 332 (1995) 1192-1197
29. Rossle M., Ochs A., Gulberg V., et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 342 (2000) 1701-1707
30. Gines P., Uriz J., Calahorra B., et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 123 (2002) 1839-1847
31. Sanyal A.J., Genning C., Reddy K.R., et al. The North American Study for the Treatment of Refractory Ascites. Gastroenterology 124 (2003) 634-641
32. Albillos A., Banares R., Gonzalez M., et al. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol 43 (2005) 990-996
33. Garcia-Tsao G., Sanyal A.J., Grace N.D., et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol 102 (2007) 2086-2102